Literature DB >> 15761658

Isolated familial somatotropinoma.

Beatriz Santana Soares1, Lawrence A Frohman.   

Abstract

The great majority of growth hormone (GH)-secreting pituitary tumors are sporadic, though a few occur with a familial aggregation, either as a component of multiple endocrine neoplasia, type 1 (MEN1) or Carney Complex, or when unassociated with other tumors, as isolated familial somatotropinomas (IFS). This report reviews the clinical and genetic information available from the 46 families reported to date with the latter syndrome. In contrast to sporadic tumors, GH-secreting tumors in IFS occur at an earlier age, especially when all affected family members are from a single generation. The IFS gene is believed to be a tumor suppressor gene, based on the presence of loss of heterozygosity. Although the gene still remains to be identified there is strong evidence for linkage to a locus of less than 10 Mb on chromosome 11q13.1-13.3.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15761658     DOI: 10.1007/s11102-005-0-04-0

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  47 in total

1.  Study of the multiple endocrine neoplasia type 1, growth hormone-releasing hormone receptor, Gs alpha, and Gi2 alpha genes in isolated familial acromegaly.

Authors:  B H Jorge; S K Agarwal; V S Lando; R Salvatori; R R Barbero; N Abelin; M A Levine; S J Marx; S P Toledo
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

Review 2.  A kindred of familial acromegaly without evidence for linkage to MEN-1 locus.

Authors:  Yoshiaki Tamura; Shun Ishibashi; Takanari Gotoda; Junko Yasufuku-Takano; Koji Takano; Keisuke Ueki; Shigeo Yamashita; Yoko Iizuka; Naoya Yahagi; Futoshi Shionoiri; Hiroaki Okazaki; Ken Ohashi; Jun-ichi Osuga; Kenji Harada; Hitoshi Shimano; Toshiro Fujita; Nobuhiro Yamada; Satoshi Kimura
Journal:  Endocr J       Date:  2002-08       Impact factor: 2.349

3.  Clinical features and therapeutic outcomes of 65 patients with acromegaly at Tokyo Women's Medical University.

Authors:  I Fukuda; N Hizuka; Y Murakami; E Itoh; K Yasumoto; A Sata; K Takano
Journal:  Intern Med       Date:  2001-10       Impact factor: 1.271

4.  Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene.

Authors:  R Salvatori; C Y Hayashida; M H Aguiar-Oliveira; J A Phillips; A H Souza; R G Gondo; S P Toledo; M M Conceicão; M Prince; H G Maheshwari; G Baumann; M A Levine
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

5.  A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to the multiple endocrine neoplasia type 1 locus at chromosome region 11q13.

Authors:  J L Stock; M R Warth; B T Teh; J A Coderre; J H Overdorf; G Baumann; R L Hintz; M L Hartman; B R Seizinger; C Larsson; N Aronin
Journal:  J Clin Endocrinol Metab       Date:  1997-02       Impact factor: 5.958

Review 6.  Familial acromegaly: case report and review of the literature.

Authors:  A Verloes; A Stevenaert; B T Teh; P Petrossians; A Beckers
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

7.  Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese.

Authors:  C Tanaka; K Yoshimoto; S Yamada; H Nishioka; S Ii; M Moritani; T Yamaoka; M Itakura
Journal:  J Clin Endocrinol Metab       Date:  1998-03       Impact factor: 5.958

8.  Four years' experiences in the treatment of pituitary adenomas with gamma knife radiosurgery.

Authors:  Y L Lim; W Leem; T S Kim; B A Rhee; G K Kim
Journal:  Stereotact Funct Neurosurg       Date:  1998-10       Impact factor: 1.875

9.  Familial acromegaly: a specific clinical entity--further evidence from the genetic study of a three-generation family.

Authors:  P Benlian; S Giraud; N Lahlou; M Roger; C Blin; C Holler; G Lenoir; J Sallandre; A Calender; G Turpin
Journal:  Eur J Endocrinol       Date:  1995-10       Impact factor: 6.664

10.  Gigantism in sibling unrelated to multiple endocrine neoplasia: case report.

Authors:  A Matsuno; A Teramoto; S Yamada; S Kitanaka; T Tanaka; N Sanno; R Y Osamura; T Kirino
Journal:  Neurosurgery       Date:  1994-11       Impact factor: 4.654

View more
  10 in total

Review 1.  Familial isolated pituitary adenomas: from genetics to therapy.

Authors:  Federica Guaraldi; Roberto Salvatori
Journal:  Clin Transl Sci       Date:  2011-02       Impact factor: 4.689

Review 2.  Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?

Authors:  Sylvia L Asa; Ozgur Mete; Shereen Ezzat
Journal:  Endocr Pathol       Date:  2021-01-12       Impact factor: 3.943

3.  Familial acromegaly due to aryl hydrocarbon receptor-interacting protein (AIP) gene mutation in a Turkish cohort.

Authors:  Mutlu Niyazoglu; Muge Sayitoglu; Sinem Firtina; Esra Hatipoglu; Nurperi Gazioglu; Pinar Kadioglu
Journal:  Pituitary       Date:  2014-06       Impact factor: 4.107

4.  Genetic analysis in a patient presenting with meningioma and familial isolated pituitary adenoma (FIPA) reveals selective involvement of the R81X mutation of the AIP gene in the pathogenesis of the pituitary tumor.

Authors:  Federica Guaraldi; Valentina Corazzini; Gary L Gallia; Silvia Grottoli; Karen Stals; Nadezhda Dalantaeva; Lawrence A Frohman; Márta Korbonits; Roberto Salvatori
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

5.  Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis.

Authors:  Rodrigo A Toledo; Berenice B Mendonca; Maria Candida B V Fragoso; Iberê C Soares; Madson Q Almeida; Michelle B Moraes; Delmar M Lourenço; Venâncio A F Alves; Marcello D Bronstein; Sergio P A Toledo
Journal:  Clinics (Sao Paulo)       Date:  2010-04       Impact factor: 2.365

Review 6.  Familial isolated pituitary adenomas: an emerging clinical entity.

Authors:  F Martucci; G Trivellin; M Korbonits
Journal:  J Endocrinol Invest       Date:  2012-12       Impact factor: 4.256

Review 7.  Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

Authors:  Albert Beckers; Lauri A Aaltonen; Adrian F Daly; Auli Karhu
Journal:  Endocr Rev       Date:  2013-01-31       Impact factor: 19.871

8.  Pituitary-specific knockout of the Carney complex gene Prkar1a leads to pituitary tumorigenesis.

Authors:  Zhirong Yin; Lisa Williams-Simons; A F Parlow; Sylvia Asa; Lawrence S Kirschner
Journal:  Mol Endocrinol       Date:  2007-11-01

Review 9.  Genomic approaches to problems in pituitary neoplasia.

Authors:  Sylvia L Asa; Shereen Ezzat
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

Review 10.  Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification.

Authors:  Ashley B Grossman; Shereen Ezzat; Sylvia L Asa; Ozgur Mete; Michael D Cusimano; Ian E McCutcheon; Arie Perry; Shozo Yamada; Hiroshi Nishioka; Olivera Casar-Borota; Silvia Uccella; Stefano La Rosa
Journal:  Mod Pathol       Date:  2021-05-21       Impact factor: 7.842

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.